Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Senators Consider Fees On PBMs To Help Close Donut Hole

This article was originally published in The Pink Sheet Daily

Executive Summary

Pharmacy benefit management companies are objecting to an idea that an annual fee on PBMs could be levied to go towards eliminating the Medicare Part D gap in drug coverage.

You may also be interested in...



As Health Reform Takes Final Shape, Pharma Provisions Still In Play

Even as news that a breakthrough on one of the major issues separating the House and Senate health care reform bills - taxing high-cost health care plans -emerged near the end of the week of Jan. 11, issues of keen interest for biopharma stakeholders remained unsettled

As Health Reform Takes Final Shape, Pharma Provisions Still In Play

Even as news that a breakthrough on one of the major issues separating the House and Senate health care reform bills - taxing high-cost health care plans -emerged near the end of the week of Jan. 11, issues of keen interest for biopharma stakeholders remained unsettled

PhRMA Deal Intact As Senate Health Reform Bill Enters Home Stretch

The $80 billion deal struck last spring between the White House, Senate Finance Committee Chairman Max Baucus, D-Mont., and the Pharmaceutical Research and Manufacturers of America remained in force as the full Senate moved toward the end of its third week of debating the bill

Related Content

Topics

UsernamePublicRestriction

Register

SC143384

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel